Template:Stroke DDX: Difference between revisions

No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 3: Line 3:
*[[Seizures]]/postictal paralysis (Todd paralysis)
*[[Seizures]]/postictal paralysis (Todd paralysis)
*[[Syncope]]
*[[Syncope]]
*[[Subdural hematoma]]
*[[Subdural hemorrhage]]
*[[Epidural hematoma]]
*[[Epidural hemorrhage]]
*[[Hypoglycemia]]
*[[Hypoglycemia]]
*[[Hyponatremia]]
*[[Hyponatremia]]
Line 11: Line 11:
*[[Labyrinthitis]]
*[[Labyrinthitis]]
*[[Drug toxicity]]
*[[Drug toxicity]]
**Lithium, phenytoin, carbamazepine
**[[Lithium toxicity|Lithium]], [[phenytoin toxicity|phenytoin]], [[carbamazepine toxicity|carbamazepine]]
*[[Bell's Palsy]]
*[[Bell's Palsy]]
*Complicated [[migraine]]
*Complicated [[migraine]]
*[[Meniere Disease]]
*[[Meniere Disease]]
*Demyelinating disease ([[MS]])
*Demyelinating disease ([[MS]])
*Conversion disorder
*[[Conversion disorder]]
*[[Transient global amnesia]]
*[[Transient global amnesia]]
*[[Giant cell arteritis]]
*[[Cerebral sinus thrombosis]]

Latest revision as of 12:40, 1 September 2019